These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3476118)

  • 21. Naftidrofuryl exerts antiserotonergic but no endothelin-receptor blocking effects in AS4.1 cells, juxtaglomerular cells and isolated perfused rat kidneys.
    Endemann D; Schweda F; Stubanus M; Ittner KP; Fischereder M; Kammerl MC; Krämer BK
    J Cardiovasc Pharmacol; 2002 Jan; 39(1):1-8. PubMed ID: 11743222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of naftidrofuryl oxalate on cerebral blood flow in elderly patients.
    James IM; Newbury P; Woolard ML
    Br J Clin Pharmacol; 1978 Dec; 6(6):545-6. PubMed ID: 728328
    [No Abstract]   [Full Text] [Related]  

  • 23. Naftidrofuryl (Praxilene) in peripheral vascular disease.
    Drug Ther Bull; 1979 Oct; 17(21):83-4. PubMed ID: 498948
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro effect of naftidrofuryl oxalate on cerebral mitochondria impaired by microsphere-induced embolism in rats.
    Takeo S; Miyake K; Minematsu R; Tanonaka K; Konishi M
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1207-14. PubMed ID: 2703971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of naftidrofuryl oxalate, a 5-HT2 antagonist, on neuronal damage and local cerebral blood flow following transient cerebral ischemia in gerbils.
    Fujikura H; Kato H; Araki T; Ban H; Hasegawa Y; Kogure K
    Brain Res; 1994 Feb; 636(1):103-6. PubMed ID: 7908849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha.
    Stinger RB; Fitzpatrick TM; Corey EJ; Ramwell PW; Rose JC; Kot PA
    J Pharmacol Exp Ther; 1982 Mar; 220(3):521-5. PubMed ID: 6950086
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of naftidrofuryl, a serotonergic antagonist, on erythrocyte aggregation.
    Nordt FJ; Jack W; Coull BM
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S29-32. PubMed ID: 1369714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of naftidrofuryl oxalate (Praxilene) on blood flow in the experimental saphenous flap model.
    Awwad AM; White RJ; Webster MH; Vance JP
    Br J Plast Surg; 1983 Oct; 36(4):460-2. PubMed ID: 6626826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of naftidrofuryl on local cerebral glucose utilization in the rat.
    Orzi F; Schuier F; Fieschi C
    J Cereb Blood Flow Metab; 1981; 1(1):137-40. PubMed ID: 7328137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of serotonergic neuronal systems in the anti-amnesic action of naftidrofuryl oxalate.
    Nabeshima T; Ichihara K; Tohyama K; Murase K; Suzuki T; Kameyama T
    Eur J Pharmacol; 1991 Nov; 205(1):55-61. PubMed ID: 1811997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propagated constriction in mouse pial arterioles: possible role of endothelium in transmitting the propagated response.
    Rosenblum WI; Weinbrecht P; Nelson GH
    Microcirc Endothelium Lymphatics; 1990; 6(4-5):369-87. PubMed ID: 2280746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study of femoral vasodilatator effects of naftidrofuryl and nicergoline on dog (author's transl)].
    Luong TN; Depin JC
    J Pharmacol; 1981; 12(3):263-75. PubMed ID: 7289623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
    Tsuchida K; Yamazaki R; Kaneko K; Aihara H
    Arzneimittelforschung; 1987 Nov; 37(11):1239-43. PubMed ID: 3481545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pregnancy-induced alterations of uterine arteriolar reactivity in the rat: observations with a new in vivo microcirculatory preparation.
    Alsip NL; Hornung JW; Henzel MK; Asher EF
    Am J Obstet Gynecol; 2000 Sep; 183(3):621-6. PubMed ID: 10992183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of serotonergic antagonism on local responses to an acute and selective endothelial trauma in vivo.
    Herrmann KS; Kreuzer H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S40-4. PubMed ID: 1369717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of naftidrofuryl on cerebral energy metabolism in mice. 2nd part].
    Meynaud A; Grand M; Belleville M; Fontaine L
    Therapie; 1975; 30(5):777-88. PubMed ID: 1221567
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of naftidrofuryl ('Praxilene') on hepatic microsomal enzymes.
    Majumdar SK; Shaw GK; Thomson AD
    Pharmatherapeutica; 1980; 2(5):305-8. PubMed ID: 6107932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic efficacy and its time course after application of naftidrofuryl in vivo.
    Herrmann KS; Grosse-Heitmeyer A; Kreuzer H
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):145-54. PubMed ID: 3827406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Capillary microscopic effect of naftidrofuryl in peripheral arterial occlusive disease].
    Heidrich H; Ranft J
    Vasa Suppl; 1988; 24():17-20. PubMed ID: 3212599
    [No Abstract]   [Full Text] [Related]  

  • 40. Serotonin-induced contractility in human saphenous vein is inhibited by naftidrofuryl.
    Vashisht R; Sian M; Sharp EJ; Leathard HL; O'Malley MK
    Br J Surg; 1992 Nov; 79(11):1154-6. PubMed ID: 1467887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.